Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.22.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of the Computation of Basic and Diluted Net Loss Per Share of Common Stock The following tables set forth the computation of basic and diluted net loss per share of common stock for the three and six months ended June 30, 2022, and common stock and preferred stock for the three and six months ended June 30, 2021 (in thousands, except share and per share amounts): 
Three Months Ended
  June 30, 2022
Common stock
Numerator:
Allocation of undistributed net loss $ (12,987)
Denominator:
Weighted average shares 9,400,902 
Basic and diluted net loss per share $ (1.38)

Six Months Ended
  June 30, 2022
Common stock
Numerator:
Allocation of undistributed net loss $ (35,038)
Denominator:
Weighted average shares 9,400,214 
Basic and diluted net loss per share $ (3.73)

Three Months Ended
  June 30, 2021
Common stock Preferred stock
Continuing Operations Discontinued Operations Continuing Operations Discontinued Operations
Numerator:
Allocation of undistributed net loss $ (16,991) $ 68  $ (183) $
Denominator:
Weighted average shares 8,014,966  8,014,966  207,221  207,221 
Basic and diluted net loss per share $ (2.12) $ 0.01  $ (0.88) $ 0.00 
Six Months Ended
  June 30, 2021
Common stock Preferred stock
Continuing Operations Discontinued Operations Continuing Operations Discontinued Operations
Numerator:
Allocation of undistributed net loss $ (45,934) $ (37) $ (1,813) $ (1)
Denominator:
Weighted average shares 7,699,923  7,699,923  729,282  729,282 
Basic and diluted net loss per share $ (5.97) $ 0.00  $ (2.49) $ 0.00 
Schedule of Anti-dilutive Securities Excluded From Computation of Diluted Weighted Shares Outstanding The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the three and six months ended June 30, 2022 and 2021, as they could have been anti-dilutive: 
  Three and Six Months Ended
June 30,
  2022 2021
Stock options 1,379,570 1,053,785
Warrants on common stock1
366,990 367,186
Restricted Stock Units 6,493
1 The weighted average number of common shares outstanding as of June 30, 2021 includes the weighted average effect of the 139,747 pre-funded warrants issued in connection with the underwritten public offering that closed in January 2021 because the exercise of such warrants requires only nominal consideration ($0.012 per share exercise price for each pre-funded warrant). During 2021, the holder exercised 25,740 of the pre-funded warrants. As of June 30, 2022, the weighted average number of common shares outstanding includes the weighted average effect of the remaining 114,007 pre-funded warrants outstanding. These pre-funded warrants are not included in the table above.